Non-specific early-onset epileptic encephalopathy
Synonyms: Non-specific EOEE · Undetermined EOEE · Undetermined early-onset epileptic encephalopathy
- Type
- Disease
- Group
- Disorder
- Inheritance
- Autosomal dominant, Autosomal recessive, Not applicable, X-linked recessive
- Age of onset
- Infancy, Neonatal
- Status
- active
A rare infantile epilepsy syndrome characterized by early onset of seizures of variable type and severity, potentially associated with a spectrum of clinical signs and symptoms including delay or lack of psychomotor development, intellectual disability, poor or absent speech development, behavioral abnormalities, hypotonia, movement disorders, spasticity, microcephaly, and dysmorphic facial features, among others. Brain imaging findings are also variable and may include cerebral atrophy or white matter abnormalities.
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Non-specific early-onset epileptic encephalopathy | Non-specific EOEE · Undetermined EOEE · Undetermined early-onset epileptic encephalopathy |
| fr | Encéphalopathie épileptique à début précoce non spécifique | Encéphalopathie épileptique à début précoce indéterminée |
| de | Enzephalopathie, epileptische, frühinfantile unbestimmte Form | Unbestimmte EOEE |
| es | Encefalopatía epiléptica inespecífica de inicio precoz | EOEE indeterminada · EOEE inespecífica · Encefalopatía epiléptica indeterminada de inicio precoz |
| it | Encefalopatia epilettica indeterminata ad esordio precoce | EOEE generica · EOEE non specificata · Encefalopatia epilettica generica ad esordio precoce |
| nl | Aspecifieke epileptische encefalopathie met vroege aanvang | Aspecifieke EOEE · Onbepaalde EOEE · Onbepaalde vroeg optredende epileptische encefalopathie |
| pt | Encefalopatia epilética de início precoce inespecífica | Encefalopatia epilética de causa indeterminada e início precoce |
| pl | Niezdeterminowana encefalopatia padaczkowa o wczesnym początku | Niezdeterminowana EOEE |
| cs | Neurčená epileptická encefalopatie s časným nástupem | Neurčená EOEE |
| uk | Неспецифічна рання епілептична енцефалопатія | Неспецифічні ЕОЕЕ · Невизначена епілептична енцефалопатія з раннім початком · Невизначений ЕОЕЕ |
| zh | 未确定的早发性癫痫性脑病 | 未确定EOEE |
| tr | Belirsiz, erken başlangıçlı epileptik ensefalopati | Belirlenmemiş EOEE |
Definition in:
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| OMIM | 301058 | BTNT | validated | |
| OMIM | 614558 | BTNT | validated | |
| OMIM | 615476 | BTNT | validated | |
| OMIM | 615833 | BTNT | validated | |
| OMIM | 615871 | BTNT | validated | |
| OMIM | 615905 | BTNT | validated | |
| OMIM | 616056 | BTNT | validated | |
| OMIM | 616339 | BTNT | validated | |
| OMIM | 616346 | BTNT | validated | |
| OMIM | 616366 | BTNT | validated | |
| OMIM | 616409 | BTNT | validated | |
| OMIM | 617020 | BTNT | validated | |
| OMIM | 617105 | BTNT | validated | |
| OMIM | 617106 | BTNT | validated | |
| OMIM | 617132 | BTNT | validated | |
| OMIM | 617153 | BTNT | validated | |
| OMIM | 617162 | BTNT | validated | |
| OMIM | 617166 | BTNT | validated | |
| OMIM | 617665 | BTNT | validated | |
| OMIM | 617711 | BTNT | validated | |
| OMIM | 617771 | BTNT | validated | |
| OMIM | 617829 | BTNT | validated | |
| OMIM | 617830 | BTNT | validated | |
| OMIM | 617831 | BTNT | validated | |
| OMIM | 617836 | BTNT | validated | |
| OMIM | 617854 | BTNT | validated | |
| OMIM | 617938 | BTNT | validated | |
| OMIM | 618008 | BTNT | validated | |
| OMIM | 618012 | BTNT | validated | |
| OMIM | 618067 | NTBT | validated | |
| OMIM | 618201 | BTNT | validated | |
| OMIM | 618396 | BTNT | validated | |
| OMIM | 618437 | BTNT | validated | |
| OMIM | 618468 | BTNT | validated | |
| OMIM | 618497 | BTNT | validated | |
| OMIM | 618557 | BTNT | validated | |
| OMIM | 618559 | BTNT | validated | |
| OMIM | 618910 | BTNT | validated | |
| OMIM | 618916 | BTNT | validated | |
| OMIM | 618959 | BTNT | validated | |
| OMIM | 619124 | BTNT | validated | |
| OMIM | 619317 | BTNT | validated | |
| OMIM | 619561 | BTNT | validated | |
| OMIM | 619605 | BTNT | validated | |
| OMIM | 619606 | BTNT | validated | |
| OMIM | 619777 | BTNT | validated | |
| OMIM | 619814 | BTNT | validated | |
| OMIM | 619881 | BTNT | validated | |
| OMIM | 619913 | BTNT | validated | |
| OMIM | 619922 | BTNT | validated | |
| OMIM | 619970 | BTNT | validated | |
| OMIM | 620028 | BTNT | validated | |
| OMIM | 620033 | BTNT | validated | |
| OMIM | 620115 | BTNT | validated | |
| OMIM | 620145 | BTNT | validated | |
| OMIM | 620149 | BTNT | validated | |
| OMIM | 620352 | BTNT | validated | |
| OMIM | 620504 | BTNT | validated | |
| OMIM | 620537 | BTNT | validated | |
| OMIM | 621608 | BTNT | validated | |
| ICD-10 | G40.4 | NTBT | attributed | validated |
| MONDO | 0018614 | E | validated | |
| UMLS | C5680057 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (6):
- ORPHA:166472Monogenic disease with epilepsy
rare genetic diseases; rare neurological diseases - ORPHA:98749Neurological channelopathy of the central nervous system due to a genetic GABA receptor defect
rare genetic diseases - ORPHA:98745Neurological channelopathy of the central nervous system due to a genetic calcium channel defect
rare genetic diseases - ORPHA:98746Neurological channelopathy of the central nervous system due to a genetic potassium channel defect
rare genetic diseases - ORPHA:98744Neurological channelopathy of the central nervous system due to a genetic sodium channel defect
rare genetic diseases - ORPHA:611314Rare syndromic intellectual disability without multiple congenital anomalies/dysmorphic syndrome
rare genetic diseases; rare neurological diseases
No children.
Codes that Orphanet moved or referred to this one:
- ORPHA:369894OBSOLETE: Early infantile epileptic encephalopathy without suppression burst referred to · inactive
Genes
55 direct| Gene | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|
| SYNGAP1 | Candidate gene tested in | Not yet assessed | HGNC:11497 | ENSG00000197283 | 603384 | 6p21.32 | synaptic Ras GTPase activating protein 1 | 23708187[PMID] |
| FGF12 | Disease-causing germline mutation(s) (gain of function) in | Assessed | HGNC:3668 | ENSG00000114279 | 601513 | 3q28-q29 | fibroblast growth factor 12 | 27164707[PMID] |
| GRIN2D | Disease-causing germline mutation(s) (gain of function) in | Assessed | HGNC:4588 | ENSG00000105464 | 602717 | 19q13.33 | glutamate ionotropic receptor NMDA type subunit 2D | 27616483[PMID] |
| HCN1 | Disease-causing germline mutation(s) (gain of function) in | Assessed | HGNC:4845 | ENSG00000164588 | 602780 | 5p12 | hyperpolarization activated cyclic nucleotide gated potassium channel 1 | 24747641[PMID]_25678871[PMID] |
| KCNA2 | Disease-causing germline mutation(s) (gain of function) in | Assessed | HGNC:6220 | ENSG00000177301 | 176262 | 1p13.3 | potassium voltage-gated channel subfamily A member 2 | 25751627[PMID] |
| SCN8A | Disease-causing germline mutation(s) (gain of function) in | Assessed | HGNC:10596 | ENSG00000196876 | 600702 | 12q13.13 | sodium voltage-gated channel alpha subunit 8 | 22365152[PMID]_23708187[PMID] |
| AARS1 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:20 | ENSG00000090861 | 601065 | 16q22.1 | alanyl-tRNA synthetase 1 | 25817015[PMID] |
| CACNA1B | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:1389 | ENSG00000148408 | 601012 | 9q34.3 | calcium voltage-gated channel subunit alpha1 B | 30982612[PMID] |
| DALRD3 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:25536 | ENSG00000178149 | 618904 | 3p21.31 | DALR anticodon binding domain containing 3 | 32427860[PMID] |
| KCNA2 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:6220 | ENSG00000177301 | 176262 | 1p13.3 | potassium voltage-gated channel subfamily A member 2 | 25751627[PMID] |
| KCNC2 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:6234 | ENSG00000166006 | 176256 | 12q21.1 | potassium voltage-gated channel subfamily C member 2 | 35314505[PMID] |
| NECAP1 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:24539 | ENSG00000089818 | 611623 | 12p13.31 | NECAP endocytosis associated 1 | 24399846[PMID] |
| TRAK1 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:29947 | ENSG00000182606 | 608112 | 3p22.1 | trafficking kinesin protein 1 | 28364549[PMID] |
| UBA5 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:23230 | ENSG00000081307 | 610552 | 3q22.1 | ubiquitin like modifier activating enzyme 5 | 27545674[PMID]_27545681[PMID] |
| UFSP2 | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:25640 | ENSG00000109775 | 611482 | 4q35.1 | UFM1 specific peptidase 2 | 33473208[PMID] |
| ACTL6B | Disease-causing germline mutation(s) in | Assessed | HGNC:160 | ENSG00000077080 | 612458 | 7q22.1 | actin like 6B | 31031012[PMID] |
| AP3B2 | Disease-causing germline mutation(s) in | Assessed | HGNC:567 | ENSG00000103723 | 602166 | 15q25.2 | adaptor related protein complex 3 subunit beta 2 | 27889060[PMID] |
| ATP1A2 | Disease-causing germline mutation(s) in | Assessed | HGNC:800 | ENSG00000018625 | 182340 | 1q23.2 | ATPase Na+/K+ transporting subunit alpha 2 | 33880529[PMID] |
| ATP1A3 | Disease-causing germline mutation(s) in | Assessed | HGNC:801 | ENSG00000105409 | 182350 | 19q13.2 | ATPase Na+/K+ transporting subunit alpha 3 | 33880529[PMID] |
| ATP6V1A | Disease-causing germline mutation(s) in | Assessed | HGNC:851 | ENSG00000114573 | 607027 | 3q13.31 | ATPase H+ transporting V1 subunit A | 29668857[PMID] |
| CACNA1A | Disease-causing germline mutation(s) in | Assessed | HGNC:1388 | ENSG00000141837 | 601011 | 19p13.13 | calcium voltage-gated channel subunit alpha1 A | 27476654[PMID] |
| CACNA2D1 | Disease-causing germline mutation(s) in | Assessed | HGNC:1399 | ENSG00000153956 | 114204 | 7q21.11 | calcium voltage-gated channel auxiliary subunit alpha2delta 1 | 35293990[PMID] |
| CDK19 | Disease-causing germline mutation(s) in | Assessed | HGNC:19338 | ENSG00000155111 | 614720 | 6q21 | cyclin dependent kinase 19 | 32330417[PMID] |
| CELF2 | Disease-causing germline mutation(s) in | Assessed | HGNC:2550 | ENSG00000048740 | 602538 | 10p14 | CUGBP Elav-like family member 2 | 33131106[PMID] |
| CLTC | Disease-causing germline mutation(s) in | Assessed | HGNC:2092 | ENSG00000141367 | 118955 | 17q23.1 | clathrin heavy chain | 29100083[PMID] |
| CNKSR2 | Disease-causing germline mutation(s) in | Assessed | HGNC:19701 | ENSG00000149970 | 300724 | Xp22.12 | connector enhancer of kinase suppressor of Ras 2 | 25223753[PMID] |
| CYFIP2 | Disease-causing germline mutation(s) in | Assessed | HGNC:13760 | ENSG00000055163 | 606323 | 5q33.3 | cytoplasmic FMR1 interacting protein 2 | 29534297[PMID] |
| DEPDC5 | Disease-causing germline mutation(s) in | Assessed | HGNC:18423 | ENSG00000100150 | 614191 | 22q12.2-q12.3 | DEP domain containing 5, GATOR1 subcomplex subunit | 36067010[PMID] |
| DHDDS | Disease-causing germline mutation(s) in | Assessed | HGNC:20603 | ENSG00000117682 | 608172 | 1p36.11 | dehydrodolichyl diphosphate synthase subunit | 29100083[PMID] |
| DNM1 | Disease-causing germline mutation(s) in | Assessed | HGNC:2972 | ENSG00000106976 | 602377 | 9q34.11 | dynamin 1 | 25262651[PMID]_25533962[PMID] |
| EEF1A2 | Disease-causing germline mutation(s) in | Assessed | HGNC:3192 | ENSG00000101210 | 602959 | 20q13.33 | eukaryotic translation elongation factor 1 alpha 2 | 23647072[PMID] |
| FBXO28 | Disease-causing germline mutation(s) in | Assessed | HGNC:29046 | ENSG00000143756 | 609100 | 1q42.11 | F-box protein 28 | 33280099[PMID] |
| FOXG1 | Disease-causing germline mutation(s) in | Assessed | HGNC:3811 | ENSG00000176165 | 164874 | 14q12 | forkhead box G1 | 31454984[PMID] |
| FZR1 | Disease-causing germline mutation(s) in | Assessed | HGNC:24824 | ENSG00000105325 | 603619 | 19p13.3 | fizzy and cell division cycle 20 related 1 | 34788397[PMID] |
| GABBR2 | Disease-causing germline mutation(s) in | Assessed | HGNC:4507 | ENSG00000136928 | 607340 | 9q22.33 | gamma-aminobutyric acid type B receptor subunit 2 | 25262651[PMID] |
| GABRA2 | Disease-causing germline mutation(s) in | Assessed | HGNC:4076 | ENSG00000151834 | 137140 | 4p12 | gamma-aminobutyric acid type A receptor subunit alpha2 | 31032849[PMID] |
| GABRA5 | Disease-causing germline mutation(s) in | Assessed | HGNC:4079 | ENSG00000186297 | 137142 | 15q12 | gamma-aminobutyric acid type A receptor subunit alpha5 | 31056671[PMID] |
| GABRB2 | Disease-causing germline mutation(s) in | Assessed | HGNC:4082 | ENSG00000145864 | 600232 | 5q34 | gamma-aminobutyric acid type A receptor subunit beta2 | 29100083[PMID] |
| GABRG2 | Disease-causing germline mutation(s) in | Assessed | HGNC:4087 | ENSG00000113327 | 137164 | 5q34 | gamma-aminobutyric acid type A receptor subunit gamma2 | 27864268[PMID] |
| KCNB1 | Disease-causing germline mutation(s) in | Assessed | HGNC:6231 | ENSG00000158445 | 600397 | 20q13.13 | potassium voltage-gated channel subfamily B member 1 | 25164438[PMID] |
| KCNH5 | Disease-causing germline mutation(s) in | Assessed | HGNC:6254 | ENSG00000140015 | 605716 | 14q23.2 | potassium voltage-gated channel subfamily H member 5 | 36307226[PMID] |
| MDGA2 | Disease-causing germline mutation(s) in | Assessed | HGNC:19835 | 14q21.3 | MAM domain containing glycosylphosphatidylinositol anchor 2 | 41570816[PMID] | ||
| NTRK2 | Disease-causing germline mutation(s) in | Assessed | HGNC:8032 | ENSG00000148053 | 600456 | 9q21.33 | neurotrophic receptor tyrosine kinase 2 | 29100083[PMID] |
| NUS1 | Disease-causing germline mutation(s) in | Assessed | HGNC:21042 | ENSG00000153989 | 610463 | 6q22.1 | NUS1 dehydrodolichyl diphosphate synthase subunit | 29100083[PMID] |
| PACS2 | Disease-causing germline mutation(s) in | Assessed | HGNC:23794 | ENSG00000179364 | 610423 | 14q32.33 | phosphofurin acidic cluster sorting protein 2 | 29656858[PMID] |
| PARS2 | Disease-causing germline mutation(s) in | Assessed | HGNC:30563 | ENSG00000162396 | 612036 | 1p32.3 | prolyl-tRNA synthetase 2, mitochondrial | 29915213[PMID] |
| PPP3CA | Disease-causing germline mutation(s) in | Assessed | HGNC:9314 | ENSG00000138814 | 114105 | 4q24 | protein phosphatase 3 catalytic subunit alpha | 28942967[PMID] |
| SCN1A | Disease-causing germline mutation(s) in | Assessed | HGNC:10585 | ENSG00000144285 | 182389 | 2q24.3 | sodium voltage-gated channel alpha subunit 1 | 24776920[PMID] |
| SCN3A | Disease-causing germline mutation(s) in | Assessed | HGNC:10590 | ENSG00000153253 | 182391 | 2q24.3 | sodium voltage-gated channel alpha subunit 3 | 29466837[PMID] |
| SLC13A5 | Disease-causing germline mutation(s) in | Assessed | HGNC:23089 | ENSG00000141485 | 608305 | 17p13.1 | solute carrier family 13 member 5 | 24995870[PMID] |
| SLC1A2 | Disease-causing germline mutation(s) in | Assessed | HGNC:10940 | ENSG00000110436 | 600300 | 11p13 | solute carrier family 1 member 2 | 27476654[PMID]_28777935[PMID] |
| SLC38A3 | Disease-causing germline mutation(s) in | Assessed | HGNC:18044 | ENSG00000188338 | 604437 | 3p21.31 | solute carrier family 38 member 3 | 34605855[PMID] |
| SYNJ1 | Disease-causing germline mutation(s) in | Assessed | HGNC:11503 | ENSG00000159082 | 604297 | 21q22.11 | synaptojanin 1 | 27435091[PMID] |
| SZT2 | Disease-causing germline mutation(s) in | Assessed | HGNC:29040 | ENSG00000198198 | 615463 | 1p34.2 | SZT2 subunit of KICSTOR complex | 23932106[PMID] |
| YWHAG | Disease-causing germline mutation(s) in | Assessed | HGNC:12852 | ENSG00000170027 | 605356 | 7q11.23 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma | 28777935[PMID] |
Prevalence and incidence
1 record| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Point prevalence | Unknown | — | Worldwide | Class only | Validated | ORPHANET |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
HPO phenotypes
48 annotations · validated 2019-01-30| HPO | Term (as annotated by Orphanet) | Diagnostic |
|---|---|---|
| Very frequent (99-80%) | ||
| HP:0001298 | Encephalopathy | |
| Frequent (79-30%) | ||
| HP:0011443 | Abnormality of coordination | |
| HP:0000750 | Delayed speech and language development | |
| HP:0002376 | Developmental regression | |
| HP:0010844 | EEG with multifocal slow activity | |
| HP:0001508 | Failure to thrive | |
| HP:0001290 | Generalized hypotonia | |
| HP:0001263 | Global developmental delay | |
| HP:0001265 | Hyporeflexia | |
| HP:0001249 | Intellectual disability | |
| HP:0001250 | Seizure | |
| Occasional (29-5%) | ||
| HP:0001273 | Abnormal corpus callosum morphology | |
| HP:0012447 | Abnormal myelination | |
| HP:0001251 | Ataxia | |
| HP:0007018 | Attention deficit hyperactivity disorder | |
| HP:0000708 | Atypical behavior | |
| HP:0000717 | Autism | |
| HP:0012444 | Brain atrophy | |
| HP:0002059 | Cerebral atrophy | |
| HP:0001558 | Decreased fetal movement | |
| HP:0000494 | Downslanted palpebral fissures | |
| HP:0100660 | Dyskinesia | |
| HP:0011968 | Feeding difficulties | |
| HP:0001288 | Gait disturbance | |
| HP:0002020 | Gastroesophageal reflux | |
| HP:0000348 | High forehead | |
| HP:0000668 | Hypodontia | |
| HP:0002521 | Hypsarrhythmia | |
| HP:0100710 | Impulsivity | |
| HP:0004305 | Involuntary movements | |
| HP:0001268 | Mental deterioration | |
| HP:0000252 | Microcephaly | |
| HP:0001336 | Myoclonus | |
| HP:0000639 | Nystagmus | |
| HP:0002421 | Poor head control | |
| HP:0000508 | Ptosis | |
| HP:0001315 | Reduced tendon reflexes | |
| HP:0002063 | Rigidity | |
| HP:0004322 | Short stature | |
| HP:0001257 | Spasticity | |
| HP:0001337 | Tremor | |
| HP:0002317 | Unsteady gait | |
| Very rare (<4-1%) | ||
| HP:0012547 | Abnormal involuntary eye movements | |
| HP:0000504 | Abnormality of vision | |
| HP:0002509 | Limb hypertonia | |
| HP:0000648 | Optic atrophy | |
| HP:0000546 | Retinal degeneration | |
| HP:0002133 | Status epilepticus | |
Run the differential on the 1 obligate / very frequent terms
Annotation source: 28777935[PMID]_27605359[PMID]_27435091[PMID]_27164707[PMID]_25223753[PMID]_23991336[PMID]_27545674[PMID]_27545681[PMID]_26235277[PMID]_26173968[PMID]_27866705[PMID]_23932106[PMID]_25817015[PMID]_24995870[PMID]_25411445[PMID]_23647072[PMID]_25751627[PMID]_25817015[PMID]_25262651[PMID]_23932106[PMID]_28364549[PMID]_25164438[PMID]_24747641[PMID]_24399846[PMID]_22365152[PMID]
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/442835
- This record as JSON: /data/d/442835.json